Investec maintains a “Buy” on Medplus Health Services, targeting Rs 940, citing growth plans and strong generics adoption. Mirae Asset Sharekhan upgrades Bajaj Finserv with a target of Rs 2,350, focusing on AI, profitable growth, and structural market opportunities. Hem Securities also recommends a “Buy” on Parag Milk, targeting Rs 255, driven by strong earnings, distribution, and value-added products.
Jio Platforms gets first Buy call! Nomura says ‘disruptor now the leader’; starts coverage with Rs 1,340 target
Shares of Jio Platforms listed at Rs 1,359 on BSE and NSE, a premium of 21% over the IPO price. Nomura set a target price